Consorcio DTx

Name

Consorcio DTx

Legal name

CONSORCIO DTx

Website

https://consorciodtx.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Therapeutics Advocacy and Policy Consortium

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro industry

PRIMARYHLACANAA

Condition-specific Digital Therapeutics (DTx)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

• Digital therapeutics advocacy
• Healthcare consortium services
• Regulatory policy advisory
• DTx ecosystem building
• Digital health research

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership and sponsorship contributions: Consorcio DTx operates as a multi-stakeholder consortium funded through membership contributions and sponsorship from pharmaceutical companies (Pfizer, Chiesi), MedTech firms, biotech companies, telecommunications firms, technology companies, insurers, CROs, investment funds, and public institutions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Consorcio DTx is a Spanish national strategic alliance (consortium) that advances the regulation, reimbursement, and adoption of digital therapeutics (DTx) within the Spanish National Health System. It facilitates multi-stakeholder co-creation among public administration, healthcare professionals, patients, caregivers, pharma/biotech/MedTech companies, startups, and hospitals. Its tangible outputs include DTx research publications (white papers, case studies, think tank reports), the CHAT DTx Spanish-language GPT knowledge tool, and a community/ecosystem engagement platform.

Product overview

Consorcio DTx is a strategic alliance focused on advancing digital therapeutics (DTx) regulation and market access in Spain, rather than a product company. Its offerings include CHAT DTx, a Spanish-language GPT-powered conversational tool providing DTx information; a DTx Resources Library containing white papers, case studies (including diabetes treatment impact), and Think Tank reports; and a community network connecting healthcare professionals, patients, and industry stakeholders. The consortium serves as a coordination and advocacy platform rather than a software product vendor.

Differentiator

Problem solved

Functional benefit

Products and services

• CHAT DTx A specialized ChatGPT-based conversational tool in Spanish that provides information about digital therapeutics, including definitions, classifications, and the latest local and global DTx updates and advances. Designed for health professionals, researchers, and stakeholders interested in DTx development, implementation, and scalability.
• White Paper 2025 - Estado actual, retos y recomendaciones para la adopción de las terapias digitales en España Updated white paper analyzing the current status, challenges, and recommendations for digital therapeutics adoption in Spain, covering regulatory changes in pioneering countries, international harmonization initiatives, success cases with digital health technologies, recently approved DTx analysis, clinical and health impact, and national initiatives.
• Caso de estudio - Impacto potencial de las terapias digitales en el tratamiento de la diabetes en España Case study analyzing how digital therapeutics can improve diabetes treatment in Spain, exploring digital solutions used in other countries, challenges in glycemic control and treatment adherence, and recommendations for gradual incorporation into the National Health System.
• Informe Think Tanks - Perspectivas e ideación de soluciones de profesionales sanitarios, pacientes e industria sanitaria Report synthesizing findings from Think Tanks conducted in 2023, providing a comprehensive view of DTx implementation in Spain, identifying intersections and divergences between healthcare professionals, patients and healthcare industry perspectives.
• DTx Resources Library Collection of high-value materials including reports, study results, practical guides, and whitepapers on digital therapeutics development, implementation, and scalability in Spain and globally.

Quantifiable outcome

• Digital therapeutics can improve treatment of diabetes in Spain, one of the most common chronic diseases in the country
• +1 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Partnerships

22 partnerships are on record, tiered flagship, core and minor.

• PfizerflagshipStrategic or Co-development PartnerPfizer is a sponsoring partner of the consortium. Pablo Sánchez Cassinello serves as Spain Digital Lead at Pfizer and represents Pfizer within the consortium's strategic partners.
• Chiesi EspañaflagshipStrategic or Co-development PartnerChiesi España is a sponsoring partner of the consortium. José Vicente Galindo serves as Pricing & Market Access Associate Director at Chiesi España.
• FEMIN (Federación Española de Empresas de Tecnología Sanitaria)coreStrategic or Co-development PartnerFEMIN (Spanish Federation of Health Technology Companies) is a sponsoring partner. Pilar Navarro Muñoz serves as Director of Innovation at FEMIN.
• OpinnocoreStrategic or Co-development PartnerOpinno, an innovation consulting firm, is a sponsoring partner contributing expertise in innovation methodology and ecosystem development.
• IESE Business SchoolcoreStrategic or Co-development PartnerIESE is an affiliate member providing academic expertise and research capabilities to the consortium's initiatives.
• MicrosoftcoreTechnology or IntegrationMicrosoft is an affiliate member contributing technology expertise and potentially cloud/AI infrastructure capabilities to support DTx initiatives.
• TecnaliacoreStrategic or Co-development PartnerTecnalia is an affiliate member and the leading technology center in Spain, providing R&D and innovation expertise.
• Vodafone Innovation EcosystemcoreStrategic or Co-development PartnerVodafone Innovation Ecosystem collaborated with the consortium on Think Tank reports synthesizing perspectives from healthcare professionals, patients, and industry.
• SEC (Sociedad Española de Cardiología)coreStrategic or Co-development PartnerSpanish Society of Cardiology is a scientific society member of the consortium, represented by Dr. Carlos Escobar from Hospital Universitario La Paz.
• SEDAR (Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor)coreStrategic or Co-development PartnerSpanish Society of Anesthesiology is part of the scientific committee, represented by Dra. Esther Méndez.
• Sociedad Española de Neumología y Cirugía Torácica (SEPAR)coreStrategic or Co-development PartnerSpanish Society of Pulmonology is represented by Dr. Juan Luis García in the scientific committee.
• Sociedad Española de Calidad AsistencialcoreStrategic or Co-development PartnerSpanish Society of Healthcare Quality is represented by Dr. Manel Santiña in the scientific committee.
• Amwell (American Well)minorStrategic or Co-development PartnerAmwell provides external advisory expertise to the consortium through Angel Enrique Roig.
• Ship2B VenturesminorStrategic or Co-development PartnerShip2B Ventures provides external advisory expertise through Maite Fibla Gasparin.
• XRHealthminorOthersDigital health startup member focused on extended reality therapeutic solutions.
• BraingazeminorOthersDigital therapy startup member focused on brain health and cognitive solutions.
• MediquominorOthersDigital health startup member providing health communication and telemedicine solutions.
• MindMazeminorOthersDigital therapy startup member focused on neuro-rehabilitation and brain health.
• Amelia Virtual CareminorOthersDigital therapy startup member focused on virtual mental health care.
• RehandminorOthersDigital therapy startup member focused on musculoskeletal rehabilitation.
• SincrolabminorOthersDigital health startup member focused on cognitive synchronization solutions.
• DTx FranceminorStrategic or Co-development PartnerFrench digital therapeutics counterpart organization, representing international DTx ecosystem connection.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/consorcio-dtx

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Consorcio DTx